Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: A critical review of randomized controlled trials

American Journal of Obstetrics and Gynecology

Volumn 170, Issue 3, 1994, Pages 910-917

  Ohlsson, Arne ^a   Myhr, Terri L ^a  

^a NONE   (Canada)

Author keywords

critical review; Group B streptococcal disease; infant newborn; infection; Streptococcus agalactiae, clinical trials

Indexed keywords

AMPICILLIN; ERYTHROMYCIN; PENICILLIN G;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LABOR; MAJOR CLINICAL STUDY; META ANALYSIS; NEWBORN; NEWBORN INFECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS AGALACTIAE;

EID: 0028235260     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(94)70307-8     Document Type: Article

References (52)

1. Review of causes of perinatal mortality in a regional perinatal center, 1980-1984
2. Septicemia of the newborn
3. Changing etiology and outcome of neonatal septicemia in Riyadh, Saudi Arabia
4. The serological differentiation of pathogenic and nonpathogenic strains of haemolytic streptococci from parturient women
5. Fatal infections by haemolytic streptococcus group B
6. Beta hemolytic streptococcus group B associated with problems of the perinatal period
7. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci
8. Perinatal group B streptococcal colonization and infection
9. Emergence of group B streptococci in obstetric and perinatal infections
10. Infections neonatales a streptocoques du groupe B constatations etiologiques. A propos de 77 observations
11. Neonatal infections caused by group B streptococci
12. B-Streptokokken als häufigste Erreger der Neugeborenensepsis. Einleitung, Häufigkeit, Klinik, Therapie
13. Neonatal septicaemia in Finland 1981-85. Predominance of group B streptococcal infections with very early onset
14. Perinatal mortality in Victoria, Australia: role of group B Streptococcus.
15. Prospects for immunizing against Streptococcus group B
16. The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital
17. Early onset neonatal group B streptococcus (GBS) infection: associated obstetric risk factors
18. Early-onset group B streptococcal sepsis: a current assessment
19. A comparison of early-onset group B streptococcal neonatal infection and the respiratory-distress syndrome of the newborn
20. Ampicillin prevents intrapartum transmission of group B streptococcus
21. Committee on Obstetrics: Maternal-Fetal Medicine, American College of Obstetricians and Gynecologists. Group B streptococcal infections: an obstetrical viewpoint
22. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis
23. Neonatal infections. II. Specific infectious diseases and therapies
24. Consensus: perinatal prophylaxis for group B streptococcal disease
25. Infection in pregnancy
26. Group B streptococcal infection in newborns. Prevention at last?
27. Intrapartum antibiotics for group B streptococcal colonisation
28. Prevention of group B streptococcal early onset sepsis: 1989
29. Group B streptococcus: the effectiveness of screening and chemoprophylaxis
30. Group B streptococcus (GBS) and neonatal infections: the case for intrapartum chemoprophylaxis
31. Physician attitudes toward applications of computer data base systems
32. Prevention of neonatal group B streptococcal disease: intrapartum detection and chemoprophylaxis of heavily colonized parturients
33. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis
34. Reduction of group B streptococcal maternal and neonatal infections in preterm pregnancies with premature rupture of membranes through a rapid identification test
35. An obstetric approach to prevention of early-onset group B β-hemolytic streptococcal sepsis
36. Prevention of neonatal group B streptococcal sepsis
37. A method for assessing the quality of a randomized control trial
38. Statistical methods for analysis of effects of treatment in overviews of randomized trials
39. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission
40. Reduction of morbidity and mortality rates for neonatal group B streptococcal disease through early diagnosis and chemoprophylaxis
41. Selective intrapartum penicillin prophylaxis of early onset group B streptococcal disease
42. Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis
43. Maternal colonization by group B streptococci and puerperal infection: analysis of intrapartum chemoprophylaxis
44. Intrapartum chemoprophylaxis of early-onset group B streptococcal disease
45. The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci
46. Guidelines for reading literature reviews
47. Chemoprophylaxis of early onset group B streptococcal disease
48. Duplicate publication and related problems
49. Intrapartum antibiotics for group B streptococcal colonisation
50. Perinatal group B streptococcal infections
51. Prevention of neonatal group B streptococcal infections: advances in maternal vaccine development